AI-generated summary
This review examines pharmacologic and non-pharmacologic treatments for male pattern hair loss, including 5-alpha reductase inhibitors, minoxidil, prostaglandins, and platelet-rich plasma. The authors report that finasteride and minoxidil are effective in arresting disease progression but allow only partial hair regrowth at best, and that earlier treatment achieves more optimal outcomes.
- Who or what was studied
- Men with androgenetic alopecia (male pattern hair loss)
- Limits stated in the abstract
- The abstract describes a narrative review with expert opinion and does not report the number of studies included or a systematic appraisal of evidence quality.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Androgenetic alopecia, Low-level laser therapy, Reactive oxygen species, Randomized controlled trial, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.